Abstract
Rare cancers (RC) defined as those with incidence <6/100000 per population, constitute a significant proportion of cancers (∼20%) when considered collectively. Challenges in diagnosis, trial recruitment, and non-standardized treatment approaches result in inferior outcomes of RC. The current study aimed to map the epidemiology of RC in SAARC countries, compile the RC list, compare it with the internationally accepted RC list (RARECAREnet)and explore the RC trends based on age, gender, regional differences.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have